REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 13 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $222,908 | +117.4% | 53,200 | +120.5% | 0.03% | +120.0% |
| Q4 2022 | $102,531 | -92.2% | 24,125 | -98.0% | 0.02% | -92.5% |
| Q2 2022 | $1,320,000 | -55.3% | 1,200,000 | 0.0% | 0.20% | -66.2% |
| Q1 2022 | $2,952,000 | -14.9% | 1,200,000 | 0.0% | 0.59% | -15.2% |
| Q4 2021 | $3,468,000 | -29.0% | 1,200,000 | 0.0% | 0.70% | -31.3% |
| Q3 2021 | $4,884,000 | -16.3% | 1,200,000 | 0.0% | 1.01% | -12.7% |
| Q2 2021 | $5,832,000 | – | 1,200,000 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $5,832,000 | 1.16% |
| EMC Capital Management | 75,835 | $257,000 | 0.15% |
| ARMISTICE CAPITAL, LLC | 714,700 | $3,473,000 | 0.06% |
| Tower Research Capital LLC (TRC) | 12,484 | $61,000 | 0.00% |
| UBS Group AG | 2,033 | $10,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 34 | $0 | 0.00% |
| NORTHERN TRUST CORP | 10,584 | $51,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 67,724 | $329,000 | 0.00% |
| Renaissance Technologies | 11,250 | $55,000 | 0.00% |